COMMUNIQUÉS West-GlobeNewswire

Dentsply Sirona Provides Update on Byte Aligner Products

24/10/2024 - 23:26

Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply [...]

Aurora Spine Corporation Announces Third Quarter 2024 Financial Results

24/10/2024 - 23:25

- Company reports record revenue and net income - - Company to host conference call on Monday, October 28 th at 11am ET/8am PT - NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, [...]

Synergy CHC Corp. Announces Closing of Initial Public Offering

24/10/2024 - 23:00

WESTBROOK, Maine, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy”), a provider of consumer health care, beauty, and lifestyle products, announced today the completion of its initial public [...]

Vision Sensing Acquisition Corp. Announces Securities Suspension Date and Redemption Amount

24/10/2024 - 22:30

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ” or “ VSAC ”), a special purpose acquisition company, announced that Nasdaq will suspend the [...]

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

24/10/2024 - 22:30

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what [...]

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement

24/10/2024 - 22:10

CARSON CITY, Nev., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]

The Ensign Group Reports Third Quarter 2024 Results; Raises Annual Earnings and Revenue Guidance

24/10/2024 - 22:07

Conference Call and Webcast scheduled for tomorrow, October 25, 2024 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign( [...]

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

24/10/2024 - 22:05

Oral Presentations to Highlight Results of Customer Collaborations using the ECO Synthesis™ Platform REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic [...]

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

24/10/2024 - 22:05

ALISO VIEJO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]

IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st

24/10/2024 - 22:05

WINTER SPRINGS, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 third quarter financial results before the market opens on Thursday, [...]

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

24/10/2024 - 22:05

MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced the closing of its [...]

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025

24/10/2024 - 22:05

Year-over-year revenue grows 11% , operating profit up 34% , non-GAAP operating profit up 27% Operating cash flow of $326 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at [...]

Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week

24/10/2024 - 22:05

WALTHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]

Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024

24/10/2024 - 22:01

HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

24/10/2024 - 22:00

Strengthens Lyell’s clinical pipeline with the addition of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate Data from ImmPACT’s multi-center Phase 1-2 clinical trial of IMPT-314 in patients with large B [...]

INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination

24/10/2024 - 21:03

Data from Animal Model Study Demonstrate XPro™ converts m icroglia from a demyelinating cell to a remyelinating cell Multi-year study published has implications for many CNS diseases including Alzheimer’s Boca Raton, [...]

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

24/10/2024 - 20:10

WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell [...]

Un chirurgien saoudien récompensé pour avoir réalisé la première transplantation cardiaque robotisée au monde

24/10/2024 - 19:21

« Intervention chirurgicale cardiaque robotisée » au KFSHRC...Un parcours de réussite à la fois pionnier et en pleine accélération RIYAD, Arabie saoudite, 24 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist [...]

Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701

24/10/2024 - 19:15

- INZ-701 was well-tolerated and significantly increased plasma pyrophosphate (PPi) levels in patients with end-stage kidney disease (ESKD) undergoing hemodialysis; low PPi levels are associated with calciphylaxis, a [...]